The Australasian Association of Clinical Biochemists and the Australian Institute of Medical Scientists 2018 Combined Scientific Meeting

Страна: Австралия

Город: Sydney

Тезисы до: 01.06.2018

Даты: 03.09.18 — 05.09.18

Область наук: Химические; Медицинские;

Е-мейл Оргкомитета: lisa@aacb.asn.au

Организаторы: The Australasian Association of Clinical Biochemists and the Australian Institute of Medical Scientists

 

The Australasian Association of Clinical Biochemists and the Australian Institute of Medical Scientists are pleased to present the AACB AIMS 2018 Combined Scientific Meeting, to be held at ICC Sydney in Sydney NSW, from the 3-5 September 2018. The meeting combines the AACB 56th Annual Scientific Conference and the AIMS 47th National Scientific Meeting.

The theme for the joint conference is “Diagnosis to Cure” and we have allocated each of the three days to explore related topics. The first day is “metabolism day” which will look at inborn metabolic syndromes and the gene and enzyme therapies that are being used to treat these. We are fortunate that this year we will be presenting the David Rothfield Memorial Oration. This is an honorary lectureship jointly sponsored by the RCPA, AACB, RCPAQAP and NATA and alternates each year between the RCPA Pathology Update and the AACB Annual Scientific Meeting. Professor Andy Hoofnagle from Washington University will be presenting the oration in 2018 with a talk on proteonomics. Carolyn Sue, Kevin Carpenter, Michael Tchan, Ian Cateson and Tina Yen will also be giving us insights into some of these conditions.

The second day is all about cancer – molecular diagnosis and classification, immunotherapies and drug treatments. We will have one of the recent recipients of the Qld Tall Poppy Science award, Dr Ken Dutton-Regester from QIMR talking about melanoma genetics and biology. The David Curnow Lecture will also be on this day.

Dr Roger Reddel will conclude the second day introducing us to Procan, a new database that Australian researchers are setting up that will feed the information gathered through analysing the proteins of 70,000 cancer samples. This will be made available worldwide and become the reference for recommending the best-known treatments for patients.

The last day will be about chronic diseases such as diabetes, kidney disease, auto-immune conditions and bleeding disorders. These diseases are a huge burden on the health system and speakers will cover topics such as monitoring response to treatments in chronic leukaemias, organ transplant surgery and biomedical ethics.

Other highlights of the meeting include the Industry Exhibition, submitted oral papers and posters, networking functions, industry symposia, meet the experts breakfast sessions and of course the gala dinner.

Веб-сайт конференции: https://www.aacb.asn.au/eventsinfo/aacb-aims-2018